Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Revenue

In the year 2023, Emergent BioSolutions had annual revenue of $1.05B, a decrease of -6.10%. Revenue in the quarter ending December 31, 2023 was $276.60M, a -16.23% decrease year-over-year.

• Revenue (ttm): $1.05B
• Revenue Growth: -6.10%
• P/S Ratio: 0.10
• Revenue / Employee: $655,813
• Employees: 1,600
• Market Cap: 100.75M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.05B	-68.20M	-6.10%
Dec 31, 2022	1.12B	-656.10M	-36.99%
Dec 31, 2021	1.77B	196.30M	12.45%
Dec 31, 2020	1.58B	471.30M	42.61%
Dec 31, 2019	1.11B	323.60M	41.36%
Dec 31, 2018	782.40M	221.50M	39.49%
Dec 31, 2017	560.90M	72.10M	14.75%
Dec 31, 2016	488.80M	-531.00K	-0.11%
Dec 31, 2015	489.33M	84.87M	20.98%
Dec 31, 2014	404.47M	91.72M	29.33%
Dec 31, 2013	312.75M	30.86M	10.95%
Dec 31, 2012	281.89M	8.50M	3.11%
Dec 31, 2011	273.38M	-12.79M	-4.47%
Dec 31, 2010	286.17M	51.39M	21.89%
Dec 31, 2009	234.79M	56.23M	31.49%
Dec 31, 2008	178.55M	-4.36M	-2.38%
Dec 31, 2007	182.92M	30.18M	19.76%
Dec 31, 2006	152.73M	22.04M	16.87%
Dec 31, 2005	130.69M	47.19M	56.52%
Dec 31, 2004	83.49M	27.73M	49.71%
Dec 31, 2003	55.77M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.